Butterfly Network (BFLY) Total Non-Current Liabilities (2020 - 2026)
Butterfly Network (BFLY) posted Total Non-Current Liabilities of $85.1 million for Q2 2026, down 1.33% sequentially from $86.2 million in Q1 2026, and up 19.84% YoY from $71.0 million in Q2 2025.
Butterfly Network (BFLY) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Butterfly Network has reported Total Non-Current Liabilities for 7 years, with the latest figure at $85.1 million in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 19.84% year-over-year to $85.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $85.1 million (up 19.84% YoY) and the FY2025 annual result came in at $92.2 million, up 17.32% from the prior year.
- Total Non-Current Liabilities eased to $85.1 million in Q2 2026 per BFLY's latest filing, from $86.2 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $101.7 million in Q1 2022 and troughed at $69.8 million in Q1 2025.
- A 5-year average of $81.1 million and a median of $79.3 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities jumped 30.2% in 2022, then declined 21.37% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $86.8 million in 2022, then decreased by 13.26% to $75.3 million in 2023, then gained by 4.36% to $78.6 million in 2024, then rose by 17.32% to $92.2 million in 2025, then retreated by 7.75% to $85.1 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $85.1 million, $86.2 million, and $92.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Butterfly Network | 2.41 Bn | 2.28 Bn | 23.29 Mn | 85.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.08 Mn |
| Mar 31, 2026 | 86.23 Mn |
| Dec 31, 2025 | 92.23 Mn |
| Sep 30, 2025 | 76.65 Mn |
| Jun 30, 2025 | 70.99 Mn |
| Mar 31, 2025 | 69.83 Mn |
| Dec 31, 2024 | 78.61 Mn |
| Sep 30, 2024 | 72.51 Mn |
| Jun 30, 2024 | 78.37 Mn |
| Mar 31, 2024 | 72.04 Mn |
| Dec 31, 2023 | 75.33 Mn |
| Sep 30, 2023 | 75.36 Mn |
| Jun 30, 2023 | 85.52 Mn |
| Mar 31, 2023 | 79.96 Mn |
| Dec 31, 2022 | 91.62 Mn |
| Sep 30, 2022 | 99.00 Mn |
| Jun 30, 2022 | 109.25 Mn |
| Mar 31, 2022 | 121.93 Mn |
| Dec 31, 2021 | 98.05 Mn |
| Sep 30, 2021 | 72.26 Mn |